254 related articles for article (PubMed ID: 10727444)
1. Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia.
Furuyama K; Sassa S
J Clin Invest; 2000 Mar; 105(6):757-64. PubMed ID: 10727444
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminolevulinate synthase in sideroblastic anemias: mRNA and enzyme activity levels in bone marrow cells.
Bottomley SS; Healy HM; Brandenburg MA; May BK
Am J Hematol; 1992 Oct; 41(2):76-83. PubMed ID: 1415186
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans.
Astner I; Schulze JO; van den Heuvel J; Jahn D; Schubert WD; Heinz DW
EMBO J; 2005 Sep; 24(18):3166-77. PubMed ID: 16121195
[TBL] [Abstract][Full Text] [Related]
4. X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2).
Bishop DF; Tchaikovskii V; Hoffbrand AV; Fraser ME; Margolis S
J Biol Chem; 2012 Aug; 287(34):28943-55. PubMed ID: 22740690
[TBL] [Abstract][Full Text] [Related]
5. Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene.
Furuyama K; Fujita H; Nagai T; Yomogida K; Munakata H; Kondo M; Kimura A; Kuramoto A; Hayashi N; Yamamoto M
Blood; 1997 Jul; 90(2):822-30. PubMed ID: 9226183
[TBL] [Abstract][Full Text] [Related]
6. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
[TBL] [Abstract][Full Text] [Related]
7. Multiple mechanisms for hereditary sideroblastic anemia.
Furuyama K; Sassa S
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):5-10. PubMed ID: 11929048
[TBL] [Abstract][Full Text] [Related]
8. Animal models for X-linked sideroblastic anemia.
Yamamoto M; Nakajima O
Int J Hematol; 2000 Aug; 72(2):157-64. PubMed ID: 11039663
[TBL] [Abstract][Full Text] [Related]
9. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase.
Cox TC; Bottomley SS; Wiley JS; Bawden MJ; Matthews CS; May BK
N Engl J Med; 1994 Mar; 330(10):675-9. PubMed ID: 8107717
[TBL] [Abstract][Full Text] [Related]
10. Heme deficiency in erythroid lineage causes differentiation arrest and cytoplasmic iron overload.
Nakajima O; Takahashi S; Harigae H; Furuyama K; Hayashi N; Sassa S; Yamamoto M
EMBO J; 1999 Nov; 18(22):6282-9. PubMed ID: 10562540
[TBL] [Abstract][Full Text] [Related]
11. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia.
Bottomley SS; May BK; Cox TC; Cotter PD; Bishop DF
J Bioenerg Biomembr; 1995 Apr; 27(2):161-8. PubMed ID: 7592563
[TBL] [Abstract][Full Text] [Related]
12. 5-aminolevulinate synthase: catalysis of the first step of heme biosynthesis.
Hunter GA; Ferreira GC
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):102-10. PubMed ID: 19268008
[TBL] [Abstract][Full Text] [Related]
13. Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis.
May BK; Bhasker CR; Bawden MJ; Cox TC
Mol Biol Med; 1990 Oct; 7(5):405-21. PubMed ID: 2095458
[TBL] [Abstract][Full Text] [Related]
14. Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA.
Cox TC; Bawden MJ; Martin A; May BK
EMBO J; 1991 Jul; 10(7):1891-902. PubMed ID: 2050125
[TBL] [Abstract][Full Text] [Related]
15. Asn-150 of Murine Erythroid 5-Aminolevulinate Synthase Modulates the Catalytic Balance between the Rates of the Reversible Reaction.
Stojanovski BM; Ferreira GC
J Biol Chem; 2015 Dec; 290(52):30750-61. PubMed ID: 26511319
[TBL] [Abstract][Full Text] [Related]
16. Biphasic ordered induction of heme synthesis in differentiating murine erythroleukemia cells: role of erythroid 5-aminolevulinate synthase.
Lake-Bullock H; Dailey HA
Mol Cell Biol; 1993 Nov; 13(11):7122-32. PubMed ID: 8413301
[TBL] [Abstract][Full Text] [Related]
17. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
[TBL] [Abstract][Full Text] [Related]
18. R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity.
Furuyama K; Uno R; Urabe A; Hayashi N; Fujita H; Kondo M; Sassa S; Yamamoto M
Br J Haematol; 1998 Dec; 103(3):839-41. PubMed ID: 9858242
[TBL] [Abstract][Full Text] [Related]
19. [Acquired, vitamin B6-responsive, primary sideroblastic anemia, an enzyme deficiency in heme synthesis].
Meier PJ; Giger U; Brändli O; Fehr J
Schweiz Med Wochenschr; 1981 Oct; 111(41):1533-5. PubMed ID: 7313623
[TBL] [Abstract][Full Text] [Related]
20. Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia.
Brownlie A; Donovan A; Pratt SJ; Paw BH; Oates AC; Brugnara C; Witkowska HE; Sassa S; Zon LI
Nat Genet; 1998 Nov; 20(3):244-50. PubMed ID: 9806542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]